The American Academy of Pain Management
The American Academy of Pain Management is an inclusive, interdisciplinary, and integrative organization serving clinicians who treat people with pain through education, setting standards of care, and advocacy.
The American Academy of Pain Management News and Research is made possible, in part, by educational grants from the following sponsers:
Clinical Trials
California
Nervous System Diseases
City: Walnut Creek
Summary: A study assessing the potential of VM202 to reduce the pain associated with painful diabetic neuropathy.
Pelvic Pain
City: San Francisco
Summary: A study to collect preliminary data on the efficacy and safety of vitamin K1 injected in an acupoint for the treatment of severe primary dysmenorrhea.
Kansas
Cumulative Trauma Disorders
City: Overland Park
Summary: A study exploring the potential usefulness of Synera for the treatment of pain associated with mild to moderate carpal tunnel syndrome.
Massachusetts
Substance-Related Disorders
City: Chestnut Hill
Summary: A study attempting to reduce the rate of prescription opioid misuse among noncompliant chronic pain patients through the use of novel tracking, education, and counseling interventions.
Missouri
Back Pain
City: St. Louis
Summary: A research study comparing two tests for low back pain.
Nebraska
Endometriosis
City: Lincoln
Summary: A study seeks individuals experiencing moderate to severe pain due to endometriosis.
New Jersey
Musculoskeletal Diseases
City: Bridgewater
Summary: A study of the effect of a single injection of SAR164877(REGN475) on reduction of pain from vertebral fracture associated with osteoporosis.
New York
Behavior and Behavior Mechanisms
City: New York
Summary: A study to determine whether 60 mg of duloxetine given once daily is better than placebo in treating associated painful symptoms in patients suffering from depression.
Texas
Arthritis
City: Lubbock
Summary: A study to determine the effects of manual therapy versus therapeutic exercise on knee osteoarthritis.
Washington
Burns
City: Seattle
Summary: A study to determine whether VR analgesia continues to be effective for reducing pain when administered for a clinically relevant treatment duration over multiple, repeated exposures.